Registered Malawi · PMRA

DIPHTHERIA&TETANUS ADSORBED-FOR ADULTS&ADOLESCENTS COMBINATION PRODUCT INJECTION

DIPHTHERIA&TETANUS_VACCINE_ADSORBED-FOR_ADULTS&ADOLESCENTS

PMPB/PL115/23 INJECTION

What it does

Adolescents are individuals aged between 10 and 19 years who experience various physical and emotional changes during this period of growth and development.

Commonly used for: supporting mental health, addressing growth and development issues, preventing substance abuse

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL115/23
Registration date
27/11/2020
Expiry date
31/03/2024
Status
Registered
Active ingredient
DIPHTHERIA&TETANUS_VACCINE_ADSORBED-FOR_ADULTS&ADOLESCENTS
Dosage form
INJECTION
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:38 · updated 2026-09-29 04:33:03

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About adolescents

Adolescents are individuals aged between 10 and 19 years who experience various physical and emotional changes during this period of growth and development.

What it treats

  • supporting mental health
  • addressing growth and development issues
  • preventing substance abuse

How it works

Adolescents undergo significant physical, emotional, and social changes, which require appropriate support and guidance.

Who it's for

This information is for parents, guardians, and healthcare providers working with teenagers.

Cautions

  • • Monitor for signs of mental health issues.
  • • Encourage healthy lifestyle choices.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About diphtheria

Diphtheria is a serious bacterial infection that affects the throat and can lead to severe complications.

What it treats

  • diphtheria (a serious throat infection)
  • prevention of diphtheria

How it works

Diphtheria is treated and prevented with vaccines that help the body build immunity against the infection.

Who it's for

This vaccine is recommended for children and adults to protect against diphtheria.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About tetanus_vaccine_adsorbed-for_adults

The tetanus vaccine helps prevent tetanus, a serious infection caused by bacteria that can enter the body through wounds.

What it treats

  • tetanus prevention
  • protection against tetanus infection

How it works

The vaccine stimulates the body to create immunity against the tetanus toxin, helping to protect you from the disease.

Who it's for

This vaccine is for adults who need vaccination against tetanus, especially if they are at risk due to injuries or have not had a recent booster.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: adolescents

Adolescents, typically defined as individuals aged between 10 and 19 years, undergo significant physical, emotional, and cognitive development. During this stage, they may face various health issues that require medical attention. The pharmacological treatment for adolescents must consider their unique developmental stage, which can affect drug metabolism, efficacy, and safety. Healthcare providers must also consider the psychosocial aspects of treatment adherence in this age group.

Indications

  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Anxiety Disorders
  • Depressive Disorders
  • Schizophrenia
  • Bipolar Disorder
  • Substance Use Disorders

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on age and weight for specific medications.

Adults: Refer to specific guidelines for the medication being prescribed, as dosages can vary greatly depending on the drug, condition, and individual patient factors.

Mechanism of action

The mechanism of action for drugs prescribed to adolescents varies widely depending on the specific condition being treated and the medication used. Common classes of medications include antidepressants, antipsychotics, and stimulants, each with distinct pathways. For example, selective serotonin reuptake inhibitors (SSRIs) increase serotonin levels in the brain, which can improve mood and anxiety symptoms.

Pharmacodynamics

Pharmacodynamics in adolescents can differ from adults due to ongoing development in the central nervous system and other organ systems. Drug effects may be influenced by hormonal changes, body composition, and metabolic rates, which can lead to variations in drug response. Adolescent patients may experience increased sensitivity to certain medications, necessitating careful monitoring and potential dose adjustments.

Pharmacokinetics

Pharmacokinetics in adolescents involves absorption, distribution, metabolism, and excretion processes that can be distinct from those in adults. The increased body surface area, hormonal fluctuations, and developing organs can impact drug clearance rates. Generally, hepatic metabolism may be more rapid in adolescents, while renal function matures throughout this period, affecting the elimination of medications. Clinicians must consider these factors when prescribing medications to this age group.

Pregnancy

Consult healthcare provider for specific recommendations, as the safety of drug use during pregnancy can vary based on the medication in question.

Breast-feeding

Consult healthcare provider before using any medication while breastfeeding, as many drugs can affect lactation or pass into breast milk.

Storage

Store in a cool, dry place away from direct sunlight and out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: diphtheria

Diphtheria is an acute bacterial infection caused by Corynebacterium diphtheriae. It primarily affects the respiratory system but can also involve the skin and other tissues. The infection is characterized by the formation of a pseudomembrane in the throat, which can lead to respiratory obstruction, and systemic effects due to the exotoxin produced by the bacteria. Diphtheria can be life-threatening if not treated promptly, and vaccination has significantly reduced its incidence in many parts of the world.

Indications

  • Prevention of diphtheria through vaccination
  • Treatment of diphtheria infection
  • Management of respiratory obstruction due to pseudomembrane

Dosage

Children: Refer to specific

Adults: Refer to specific guidelines for the treatment of diphtheria. Antitoxin and antibiotics are typically used in treatment.

Mechanism of action

The pathogenicity of Corynebacterium diphtheriae is largely due to its production of diphtheria toxin, an A-B toxin that inhibits protein synthesis in host cells. The toxin is composed of two subunits: the A subunit, which enters the cytoplasm of the cell and catalyzes the ADP-ribosylation of elongation factor 2 (EF-2), leading to cell death, and the B subunit, which binds to the cell surface receptor, facilitating the entry of the A subunit. This results in local tissue damage and systemic effects, including myocarditis and neuropathy.

Pharmacodynamics

Diphtheria toxin exerts its effects primarily through inhibiting protein synthesis, causing cell death in susceptible tissues. The resulting necrosis can lead to the characteristic pseudomembrane formation in the throat and can affect other organs, including the heart and nervous system. The immune response to the toxin and the bacteria provides some level of protection, which is the basis for vaccination strategies.

Pharmacokinetics

The pharmacokinetics of the diphtheria toxin itself are not typically described in terms of absorption, distribution, metabolism, and excretion, as it is a potent toxin rather than a conventional drug. However, the body’s immune response to the toxin is crucial for recovery. After vaccination, the body generates antibodies against the toxin, which can neutralize its effects upon exposure to the bacterium.

Pregnancy

Diphtheria vaccination is recommended during pregnancy to protect the mother and fetus. The vaccine is inactivated and poses no risk.

Breast-feeding

Diphtheria vaccination is safe during breastfeeding. Antibodies may be transferred to the infant through breast milk.

Storage

Store in a refrigerator at 2-8 degrees Celsius. Do not freeze.

Formulations

  • Diphtheria toxoid vaccine

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.